The transcription factor NFKB1 and the microRNA has-miR-126-5p, along with the gene AGAP11, form a regulatory network that may influence GRM1 expression in CML, suggesting a complex interplay of regulatory elements in the disease’s molecular profile. The gene discussed is AGAP11; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.